The obesity duopoly has been pierced as Amgen positions itself to have a drug on the market in a few years. While this adds ...

Gov. Eric J. Holcomb honored Clay Robbins, chairman and CEO of Lilly Endowment, Inc., with the 2024 Sachem Award. A ceremony was held for friends, family and colleagues to celebrate Robbins as the ...

Shares of Eli Lilly & Co. LLY inched 0.91% higher to $795.35 Friday, on what proved to be an all-around favorable trading ...

After 10 long years, the company that has developed a collagen biomaterial to help heal tissue is readying itself for its ...

Mean duration of Crohn's disease was 7.4 years. Nearly half (48.5%) had previous biologic therapy failure, 45.7% had previous ...

Mark Plemmons' Friday Five includes Page Castrodale leaving the Cabarrus EDC for a job with Eli Lilly, N.C. Sen. Paul Newton ...

We are grateful to our colleagues for their interest and thoughtful comments on our Seminar about systemic lupus erythematosus (SLE).1 We appreciate the remarks from Qihe Xu, and Thomas Pabst and ...

Eli Lilly (NYSE: LLY) is the most valuable healthcare stock in the world, with a market capitalization of nearly $700 billion ...

Eli Lilly’s strong position in GLP-1 drugs is overlooked by the market. Find out why LLY stock is a buy even as others pull ...

Whoever says the Food and Drug Administration is too cozy with Big Pharma isn’t paying attention to the bonanza of new ...

One of the Charlotte region's top economic development players has been hired by a pharmaceutical giant establishing a ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.